Wellgistics Health, Inc.
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Prashant Patel
- Full Time Employees
- 31
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Address
- 3000 Bayport Drive Tampa FL United States of America 33607
- IPO Date
- Feb 25, 2025
- CIK
- 0002030763
- Website
- wellgisticshealth.com
- Similar Companies
- Business
- Wellgistics Health, Inc. operates as a healthcare technology and pharmaceutical logistics company specializing in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies across the United States. Its core offerings include generic and branded pharmaceuticals, over-the-counter healthcare and consumer products, third-party logistics services featuring warehousing, inventory management, pick and pack, and shipping tailored to small and mid-size pharmaceutical manufacturers. The company also operates the DelivMeds platform, a pharmaceutical hub that facilitates prescription transfers and provides backend clinical concierge services to a network of independent pharmacies, along with managing a retail community specialty pharmacy. Founded in 2022 and headquartered in Tampa, Florida, Wellgistics Health has developed an integrated micro health ecosystem through strategic acquisitions, including Wood Sage and Wellgistics LLC, bringing in subsidiaries focused on pharmaceutical technology hubs and specialty pharmacy services. Recently, the company executed partnerships with Tollo Health and Protega Pharmaceuticals to market novel medical food products and expand pharmacist education and patient access to FDA-approved abuse-deterrent opioids. Additionally, Wellgistics Health is advancing digital transformation in the pharmaceutical supply chain through strategic alliances such as with DataVault AI to implement blockchain-enabled smart contracts aimed at ensuring safe, timely, and efficient medication delivery. The company completed its IPO in February 2025, raising $4 million to fund AI-driven initiatives designed to optimize inventory forecasting, prescription fulfillment, and streamline pharmacy services, positioning it as an innovative player enhancing access, transparency, and trust in U.S. healthcare pharmacy logistics.
DataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital Markets
WELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC.
Wellgistics Health Announces Updated Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders
Rubenstein Public Relations Named Agency of Record for Wellgistics Health, Inc.
Wellgistics Health Appoints Brett Thompson as Chief Technology Officer
Wellgistics Health Executive Chairman and President Exercise Warrants
DataMeds AI, Inc. Selected as Proposed New Name for Wellgistics Health, Inc.
Wellgistics Health Provides Mid-Year 2026 Corporate Outlook
Wellgistics Health Announces Lock-Up Agreement with Holders of a Majority of its Common Stock
Wellgistics Health Refinances Outstanding Convertible Debt and Raises $6.5M
Wellgistics Health Completes Reverse Split
CORRECTION FROM SOURCE: Wellgistics Health Releases Letter to Our Shareholders
Wellgistics Health Releases Letter to Our Shareholders
Why Wellgistics Health (WGRX) Stock Fell Over 24% After Hours?
Wellgistics Health Announces Reverse Stock Split
Wellgistics Health and Datavault AI to Form DelivMeds AI via PharmacyChain™ License Expansion and Acquisitions of QOLPOM Biometric Health Data and Drone Logistics IP and Majority of Tollo Health
Wellgistics Health and Datavault AI to Form DelivMeds AI via PharmacyChain™ License Expansion and Acquisitions of QOLPOM Biometric Health Data and Drone Logistics IP and Majority of Tollo Health
Wellgistics Health Reports First Quarter 2026 Financials and Provides Business Update
Wellgistics Health to Announce First Quarter 2026 Financials on Tuesday May 19, 2026
Wellgistics Health Announces Pilot MSO Collaboration with Kare PharmTech Targeting $14 Billion U.S. Market for CCM and RPM Services